A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses
Launched by ALCON RESEARCH · Mar 23, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study includes a retrospective chart review for pre-operative, operative, and post-operative data collection, and a prospective, standard-of-care visit to collect study endpoints.
Gender
ALL
Eligibility criteria
- Key Inclusion Criteria:
- • Subject is implanted with one of the study IOL models between 3 and 5 years previously.
- • Subject follow-up is expected to be possible during the duration of the study.
- • Subject or legally authorized representative must be able to understand and sign the IRB/EC approved Informed Consent form. Minor subjects will complete an Assent Form.
- • Documented medical history and required pre-operative baseline information is available for retrospective data collection.
- Key Exclusion Criteria:
- • Subject is participating in a separate investigational drug or device study.
- • Pregnancy at the time of enrollment.
About Alcon Research
Alcon Research is a leading global company dedicated to advancing eye care through innovative research and development. As a subsidiary of Novartis, Alcon focuses on the development of cutting-edge products and therapies for vision correction and eye health, including surgical, pharmaceutical, and consumer eye care solutions. With a commitment to enhancing the quality of life for patients worldwide, Alcon Research conducts rigorous clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of care. Through collaboration with healthcare professionals and institutions, Alcon remains at the forefront of ophthalmic advancements, driving progress in the field of vision science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Jacksonville, Florida, United States
Rock Island, Illinois, United States
Babylon, New York, United States
San Juan, , Puerto Rico
Fort Worth, Texas, United States
Burbank, California, United States
Patients applied
Trial Officials
Clinical Lead, Surgical
Study Director
Alcon Research, LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials